For a patient with type 2 diabetes on insulin glargine 22 units daily, carbohydrate‑to‑insulin ratio 1:8, insulin sensitivity factor 1:25, who received dexamethasone 20 mg 24 hours ago and now has overnight glucose 326 mg/dL and fasting glucose 296 mg/dL, what should the basal insulin dose, carbohydrate‑to‑insulin ratio, and correction factor be?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Adjustment for Steroid-Induced Hyperglycemia

Increase your Lantus to 33 units (50% increase), tighten your carb ratio to 1:6, and adjust your correction factor to 1:20 to manage the dexamethasone-induced hyperglycemia.

Rationale for Basal Insulin Increase

Your current fasting glucose of 296 mg/dL and overnight glucose of 326 mg/dL represent significant hyperglycemia requiring immediate intervention. For glucocorticoid-induced hyperglycemia, increasing basal insulin by 40-60% or more is often necessary 1, 2. Given dexamethasone's long-acting nature (unlike prednisone which peaks in 4-6 hours), you need sustained basal coverage throughout the day 1, 2.

Starting with a 50% increase (from 22 to 33 units) is appropriate because:

  • Your fasting glucose is nearly 200 mg/dL above target
  • Dexamethasone 20 mg is a substantial dose causing profound insulin resistance 3
  • The ADA guidelines specifically note that higher steroid doses require 40-60% or more increases in insulin 1, 2

Consider switching your Lantus timing from evening to morning 4, as this better matches dexamethasone's pharmacodynamics and prevents overnight hyperglycemia while maintaining daytime coverage.

Carbohydrate Ratio Adjustment

Your current 1:8 ratio is insufficient given your elevated glucose levels. Tighten to 1:6 (one unit per 6 grams of carbohydrate), representing approximately a 25-30% increase in mealtime insulin. This adjustment accounts for:

  • Steroid-induced peripheral insulin resistance affecting glucose uptake 3
  • The need for proportionally more prandial insulin when on higher glucocorticoid doses 1, 2

Monitor pre- and post-meal glucose levels closely. If post-meal excursions exceed 180 mg/dL consistently, further tighten to 1:5.

Correction Factor (ISF) Adjustment

Adjust your ISF from 1:25 to 1:20 (one unit lowers glucose by 20 mg/dL instead of 25 mg/dL). This 20% increase in correction insulin sensitivity reflects the decreased insulin effectiveness during steroid therapy.

Apply corrections every 4 hours if using rapid-acting insulin, or every 6 hours if using regular insulin 1, 2. Target pre-meal glucose of 100-180 mg/dL 2.

Critical Monitoring and Titration

Daily adjustments are essential 1, 2. Use this algorithm:

  • If fasting glucose >150 mg/dL for 2-3 consecutive days: Increase Lantus by 2-4 units (10-15% increments) 4
  • If fasting glucose <80 mg/dL: Decrease Lantus by 10-20% 4
  • If post-meal glucose consistently >180 mg/dL: Further tighten carb ratio by one unit (move from 1:6 to 1:5)
  • If experiencing hypoglycemia <70 mg/dL: Immediately reduce the corresponding insulin component by 10-20% 4

Important Caveats

Hypoglycemia risk increases significantly with these adjustments. Check glucose before each meal and at bedtime. Have fast-acting carbohydrates readily available (15-20 grams to treat glucose <70 mg/dL).

As dexamethasone effects wane (typically 24-72 hours after the last dose), you'll need to rapidly de-escalate insulin to prevent severe hypoglycemia. Plan to reduce basal insulin by 20-30% once steroid effects diminish, then titrate down further based on glucose trends.

NPH insulin is an alternative approach specifically mentioned for steroid-induced hyperglycemia 4, 1. If hyperglycemia persists despite Lantus increases, consider adding NPH insulin in the morning (starting 5-10 units) to match the daytime hyperglycemic pattern caused by dexamethasone, while maintaining your evening Lantus at a lower dose.

Contact your provider if:

  • Glucose remains >250 mg/dL despite adjustments for 48 hours
  • You experience glucose <70 mg/dL more than once
  • You develop symptoms of DKA (nausea, vomiting, abdominal pain, rapid breathing)

The combination of increased basal insulin, tightened carb ratio, and adjusted correction factor addresses the multi-faceted insulin resistance caused by high-dose dexamethasone while maintaining safety through frequent monitoring and systematic titration 1, 2.

Related Questions

For a patient with type 2 diabetes who received dexamethasone 1 mg 48 hours ago and is using insulin glargine (Lantus) 16 U daily with carbohydrate‑to‑insulin ratios of 1 U/4 g (breakfast and lunch), 1 U/5 g (dinner), and 1 U/6 g (snack) plus a high correction factor, how should the carbohydrate ratios be reduced?
For a patient with type 2 diabetes (A1c 8.0 %, hemoglobin 8.2 g/dL, BMI 35, weight 109 kg) who received dexamethasone 20 mg yesterday, is currently on insulin glargine (Lantus) 22 U with a 1 U:8 g carbohydrate ratio and an insulin sensitivity factor of 1 U per 25 mg/dL, and has recent glucose readings of 386 mg/dL and 326 mg/dL, what should the basal insulin glargine dose be today now that dexamethasone will not be given?
In a patient with type 2 diabetes mellitus, how should regular insulin be administered using an eight‑hour sliding‑scale regimen?
Can calcium be administered in a dextrose (glucose) solution?
In a 78-year-old male with an A1c of 9.1% who is prescribed 14 units of insulin glargine (Lantus) daily plus a sliding‑scale insulin, how should his insulin regimen be managed?
Should immediate imaging be avoided for a 51-year-old woman with subacute symmetric progressive lower‑extremity weakness, gait instability, hypotonia, and reduced reflexes, without pain, fever, sensory loss, trauma, or known chronic disease?
How does Lasix (furosemide) act in a patient with fluid retention?
What is the appropriate treatment for orchiepididymitis?
What are the indications for hospital admission in patients with radiation‑induced cystitis?
Is cephalexin safe for use during pregnancy?
What is the recommended immediate management for a 25-year-old woman with anasarca, moderate pre‑eclampsia, anemia, postpartum eclampsia, elevated portal vein peak systolic velocity indicating portal hypertension, and splenomegaly?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.